NAOMI CLIFTON-HERNANDEZ: Open Payments
NPI 1053961003 · SAN ANTONIO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,757 in 69 payments from 18 companies in 2025. Trend: 2023 $457 · 2024 $741 · 2025 $1,757
Food & beverage: $1,657Education: $100
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 14 | $445 |
| Amgen Inc. | 19 | $362 |
| UCB, Inc. | 5 | $207 |
| ANI Pharmaceuticals, Inc. | 7 | $155 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $154 |
| Mallinckrodt Hospital Products Inc. | 4 | $74 |
| E.R. Squibb & Sons, L.L.C. | 3 | $56 |
| AstraZeneca Pharmaceuticals LP | 3 | $55 |
| Fresenius Kabi USA, LLC | 2 | $51 |
| SOBI, INC | 1 | $30 |
Products named: TREMFYA, Bimzelx, PURIFIED CORTROPHIN GEL, OTEZLA, KRYSTEXXA, ACTHAR, ORENCIA, SAPHNELO.
Industry payments across TX — which companies pay providers there.
